Nacuity Pharmaceuticals
Operator of a biotechnology company intended to offer treatments for retinitis pigmentosa and other ophthalmological disorders. The company offers drug candidates focused on treating ocular oxidative ...
Valuation
$0
Share Price
N/A
Total Raised
$32.2M
Last Round
N/A